Comparison of Treatment Effects Between US and Non-US Study Sites in Multiregional Alzheimer Disease Clinical Trials
Conclusions:
It appears that there is no clear evidence to suggest that MRCTs should not be used to study AD.
Source: Therapeutic Innovation and Regulatory Science - Category: Drugs & Pharmacology Authors: Luan, J. J., Mani, R., Hung, H. M. J. Tags: Global Perspectives Source Type: research
More News: Alzheimer's | Clinical Trials | Drugs & Pharmacology | Neurology | Neuroscience | New Drug Applications | Science | Study